| abstract |
The present application relates to compounds of formula (I) and their salts and solvates: wherein R 1 , R 2 , R 3 , A 1 , A 2 , A 3 and n are as described in this specification, as well as relating to their preparation, pharmaceutical compositions comprising them, and their use in therapy and/or Use to prevent lysosomal storage diseases such as Gaucher disease and other diseases or disorders that are synucleinopathies. |